ProfoundBio

Seattle, United States

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

$112.0M raised

Feb 2024

Series B

Top Investors

HSGRA Capital ManagementOrbiMedGaorong CapitalK2VC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ProfoundBio raised?

ProfoundBio has raised $112.0M in total funding. The most recent round was Series B. The last funding was announced in February 2024.

Who are ProfoundBio's investors?

ProfoundBio's investors include HSG, RA Capital Management, OrbiMed, Gaorong Capital, K2VC.

Where is ProfoundBio headquartered?

ProfoundBio is headquartered in Seattle, United States.

What does ProfoundBio do?

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

What stage is ProfoundBio at?

ProfoundBio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 13, 2024.

MLA

"ProfoundBio — Funding & Investors." VCBacked, February 13, 2024, https://www.vcbacked.co/company/profoundbio. Accessed June 4, 2026.

APA

VCBacked. (2024). ProfoundBio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/profoundbio

Wikipedia (cite web)

{{cite web |title=ProfoundBio — Funding & Investors |url=https://www.vcbacked.co/company/profoundbio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 13, 2024.